Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NIHD
2726
DELISTED
NII Holdings, Inc. Common Stock
NIHD
| $640K | ﹤0.01% |
1,392,198
-436,927
| -24% | -$257K |
|
|
AGRX
2727
DELISTED
Agile Therapeutics
AGRX
| $639K | ﹤0.01% |
72
+7
| +11% | +$53.8K |
|
|
CHSP
2728
DELISTED
Chesapeake Lodging Trust
CHSP
| $639K | ﹤0.01% |
+23,679
| New | +$599K |
|
2729
WD-40
WDFC
$2.87B
| $638K | ﹤0.01% |
5,703
+1,785
| +46% | +$193K |
|
|
RELY
2730
DELISTED
Real Industry, Inc.
RELY
| $638K | ﹤0.01% |
354,459
-16,731
| -5% | -$35.6K |
|
|
ECYT
2731
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $637K | ﹤0.01% |
451,861
-238,769
| -35% | -$333K |
|
2732
Jakks Pacific
JAKK
$299M
| $636K | ﹤0.01% |
21,184
+1,383
| +7% | +$46.9K |
|
2733
Quad
QUAD
$526M
| $636K | ﹤0.01% |
28,132
-68,455
| -71% | -$1.42M |
|
2734
Perdoceo Education
PRDO
$2.09B
| $635K | ﹤0.01% |
61,099
-208,826
| -77% | -$1.94M |
|
|
GWR
2735
DELISTED
Genesee & Wyoming Inc.
GWR
| $633K | ﹤0.01% |
8,559
-15,402
| -64% | -$1.05M |
|
2736
StoneX
SNEX
$8.4B
| $632K | ﹤0.01% |
+83,531
| New | +$611K |
|
2737
Sensata Technologies
ST
$6.14B
| $631K | ﹤0.01% |
+13,119
| New | +$593K |
|
|
OXFD
2738
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $630K | ﹤0.01% |
37,520
-1,424
| -4% | -$23.2K |
|
2739
Smart Sand
SND
$199M
| $627K | ﹤0.01% |
92,450
+54,879
| +146% | +$353K |
|
2740
MGE Energy Inc
MGEE
$2.99B
| $623K | ﹤0.01% |
9,644
-67,019
| -87% | -$4.34M |
|
|
OLP
2741
One Liberty Properties
OLP
$538M
| $623K | ﹤0.01% |
+25,571
| New | +$615K |
|
2742
Vanguard High Dividend Yield ETF
VYM
$83.1B
| $623K | ﹤0.01% |
7,682
-3,844
| -33% | -$305K |
|
|
UNT
2743
DELISTED
UNIT Corporation
UNT
| $622K | ﹤0.01% |
+30,223
| New | +$539K |
|
|
NMRX
2744
DELISTED
Numerex Corp
NMRX
| $619K | ﹤0.01% |
162,953
-16,744
| -9% | -$69.5K |
|
|
AGFS
2745
DELISTED
AgroFresh Solutions Inc
AGFS
| $616K | ﹤0.01% |
+87,657
| New | +$658K |
|
2746
LSI Industries
LYTS
$758M
| $610K | ﹤0.01% |
92,236
+39,481
| +75% | +$276K |
|
2747
Community Health Systems
CYH
$419M
| $608K | ﹤0.01% |
79,175
-253,554
| -76% | -$1.98M |
|
2748
Costamare
CMRE
$1.91B
| $607K | ﹤0.01% |
98,162
-17,579
| -15% | -$114K |
|
2749
Chunghwa Telecom
CHT
$33.5B
| $605K | ﹤0.01% |
17,728
-15,482
| -47% | -$533K |
|
2750
Granite Construction
GVA
$5.42B
| $603K | ﹤0.01% |
+10,410
| New | +$549K |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.